here - Stark Oncology Consulting by pengxuebo

VIEWS: 7 PAGES: 17

									                          CURRICULUM VITAE

                     JAMES J. STARK, M.D., F.A.C.P.

BORN          October 3, 1945

ADDRESS       116 Settlers Landing Road
              Suffolk VA 23435-1740

TELEPHONE     (757) 484-0098;
              (757) 676-6354 (cell)

E-MAIL        jjstark@StarkOncology.com

WEBSITE       http://www.StarkOncology.com

BLOG:         http://starkoncologyconsulting.wordpress.com/

EDUCATION AND EXPERIENCE

1967          B.A. Yale University, cum laude

1971          M.D. Harvard Medical School, cum laude

1971-1973     Internship and Residency in Internal Medicine at Barnes Hospital and
              Washington University, St. Louis, Missouri

1973-1975     Active Duty, United States Public Health Service,
              National Health Service Corps, Philadelphia, PA

1975-1977     Fellowship in Medical Oncology at Dana-Farber Cancer Institute,
              Harvard Medical School and Brigham and Women's Hospital

1977-1988     Staff Physician, NDC Medical Center, Norfolk, VA (private practice)

1978-1982     Assistant Professor of Medicine, Eastern Virginia Medical School,
              Norfolk, VA (community faculty)

1983-1988     Associate Professor of Medicine, Eastern Virginia Medical School,
              Norfolk, VA (community faculty)

1988-1992     Full-time faculty as Chief, Hematology and Medical Oncology,
              Eastern Virginia Medical School and Associate Professor of Medicine

1992-1993     Chief of Medical Oncology, Midwestern Regional Medical Center,
              Cancer Treatment Centers of America, Zion, IL


                                                                                  Apr-12
                                James J. Stark, M.D., F.A.C.P. p.2




1993-2002            Medical Director, Cancer Treatment Centers of America;
                     President, Professional Corporation of Virginia, CTCA

1995-1998            Medical Director, Integrated Oncology Networks, CTCA

1997-2002            Associate Professor of Medicine, Eastern Virginia Medical School

2002-2011            Medical Director, Cancer Program, Maryview Medical Center,
                     Portsmouth, VA

2002-2008            Private solo practice of Hematology and Medical Oncology

2002-present         Professor of Clinical Internal Medicine, Eastern Virginia Medical School

2005-present         Medical Director of Palliative Care, Maryview Medical Center

2006-2008            Medical Director of Hospice Program, Bon Secours Hampton Roads

2008-2011            Staff Physician, Oncology Division, Riverside Medical Group

2011-present         President, StarkOncologyConsulting

2011-present         Consultant to leadership group, Bon Secours Hampton Roads

Current Licensure:   Virginia

CERTIFICATIONS

1972                 National Board of Medical Examiners

1975                 American Board of Internal Medicine

1977                 Subspecialty of Medical Oncology

MEMBERSHIPS

                     American College of Physicians* (Elected, 1979; Fellow, 1999)
                     American Society of Clinical Oncology* (Elected, 1979)
                     Cancer Biotherapy Research Group (1988-2000)
                     Southwest Oncology Group (1989-1992)
                     National Surgical Adjuvant Breast and Bowel Project (1989-1992)
                     Society for Biological Therapy (1988-2008)
                     American College of Physician Executives (1993-1999)
                     Portsmouth Academy of Medicine*
                     Medical Society of Virginia*
                         James J. Stark, M.D., F.A.C.P. p.3


               American Medical Association (1993-1999)
                                                                            *
                                                                             currently held

PRIOR HOSPITAL AFFILIATIONS

               Bon Sccours Maryview Medical Center, Portsmouth
               Bon Secours DePaul Medical Center, Norfolk, VA
               Riverside Regional Medical Center, Newport News
               Sentara Hospitals, Norfolk and Suffolk
               Chesapeake Regional Medical Center, Chesapeake


PROFESSIONAL AND COMMUNITY ACTIVITIES AND AWARDS

1978-1992      Tidewater Cancer Network

1978-1983      Board of Directors, Tidewater Chapter of American Cancer Society

1981-1983      Board of Directors, American Society of Internal Medicine, Virginia
               Chapter

1981-1983      Physician Advisory Board, Blue Shield of Virginia

1981-1984      Board of Directors, NDC Medical Center

1982-1985      Board of Directors, Virginia Symphony

1984-1988      Director, Cancer Detection Project of NDC Medical Center

1987-1990      Medical Director, Oncology Special Care Unit, Sentara Norfolk
               General Hospital

1988-1992      Director, Tidewater Cancer Network

1988-1992      Principal Investigator, Norfolk Site, National Biotherapy Study Group

1988-1992      Member, Cancer Executive Committee, Sentara Norfolk General
               Hospital

1990-1995      Board of Directors, National Biotherapy Study Group

1990-1996      Study Chairman, Melanoma, Adenocarcinoma, Kaposi's Sarcoma and
               Bladder Cancer and Chronic Leukemia Protocols, NBSG

1992-1994      Parent fund-raiser, Phillips Academy, Andover, MA
                         James J. Stark, M.D., F.A.C.P. p.4


1993-present   Member, Cancer Leadership Council, Maryview Medical Center

1993-present   Member, Cancer Committee, Maryview Medical Center

1994-2000      Principal Investigator, Cancer Biotherapy Research Group

1994-present   Board of Advisors, Lee’s Friends

1994-2002      Chairman of Research Advisory Committee, CTCA

1995-1996      Parent Advisory Board to President of Purdue University, West Lafayette,
               IN

1996-2000      President’s Council, Purdue University, Cornerstone Member

1996-1999      Member ex-officio Board of Scientific Counselors, Cancer Treatment
               Research Foundation

1997-1998      Member, Cancer Committee, Eastern Virginia Medical School

1999-2002      Voting Member, Board of Scientific Counselors, Cancer Treatment
               Research Foundation

2000-present   Medical Advisor, British Broadcasting Corporation (BBC)

2001-2003      Advisory Board to CEO of Maryview Medical Center on physician
               succession (retirement and replacement)

2002-2004      Physician representative to Committee on Complementary and Alternative
               Medicine, Maryview Medical Center

2002-2008      Monthly lecture series to the Maryview Nursing Services on oncology
               topics

2003           Ministering Spirit Award of Bon Secours Health System, presented on
               December 5.

2005-2009      Board of Directors, Leukemia and Lymphoma Society, Virginia Chapter

OTHER PROFESSIONAL ACTIVITIES

1996-present   Co-founder, Stark Software

2000-2002      Founder: Cancer Options, Website and Internet Company
               http://www.cancer-options.net
                                James J. Stark, M.D., F.A.C.P. p.5


2000-2006            Consultant to: IT Medica, a software development company specializing
                     in measuring cancer outcomes

2004-present         Editorial Boards, Cancer Investigation; Nutrition and Cancer: An
                     International Journal; Medical Science Monitor; Case Reports and
                     Clinical Practice Review; Ophthalmic Plastic and Reconstructive
                     Surgery; Indian Journal of Ophthalmology

2011-present         Consultant to Virginia Board of Medicine


COURSES TAUGHT AND SYMPOSIUM PRESENTATIONS (Professional and
Community)

Participant in tumor boards and cancer conferences, Sentara Norfolk General Hospital, De Paul
Hospital and Maryview Medical Center, 1977-present.

1978: Medical Grand Rounds in advances in medical oncology, EVMS.

       Presented paper on Testicular Cancer at annual meeting of Virginia Chapter of American
       College of Physicians.

1982: symposium on lung cancer.

       symposium on advances in hematology and oncology.

1984: symposium on skin cancer jointly sponsored by EVMS and Chesapeake General
      Hospital.

1988: Biotherapy symposium sponsored by Sentara Norfolk General Hospital.

1988-1990: Board Review Course sponsored by Department of Internal Medicine, EVMS:
      Review of Medical Oncology

1989: CME course on topics in Internal Medicine (discussed breast cancer).

1990: symposium on immediate breast reconstruction sponsored by EVGSM and Department of
      Plastic Surgery.

       CME course on topics in Internal Medicine (discussed cancer detection).

       Symposium on breast cancer sponsored by Sentara Norfolk General Hospital.

       Medical Grand Rounds, EVMS on advances in GI malignancy.
                                James J. Stark, M.D., F.A.C.P. p.6


1991: Symposium on breast reconstruction sponsored jointly by EVGSM and University of
      Florida School of Medicine.

       Symposium on Topics in Family Medicine sponsored by EVGSM, on cancer detection
       and treatment.

       Symposium on breast cancer sponsored by Tidewater Regional Cancer Network.

1992: Chaired session and presented paper on melanoma research at annual scientific meeting
      of Virginia Chapter of American Cancer Society

       Director, Biotherapy Symposium, sponsored by National Biotherapy Study Group,
       Sentara Cancer Institute and Division of Hematology/Oncology, EBMS

1993: Guest speaker (topic: advances in Biotherapy) in Oncology nursing seminar on recent
      developments in oncology, sponsored by Midwestern Regional Medical Center; held in
      Gurnee, IL.

       Speaker at Medical Grand Rounds, Midwestern Regional Medical Center; subject:
       Cancer Detection -- 1993.

       Speaker at Medical Grand Rounds, Chicago Medical School, North Chicago, IL; subject:
       Adjuvant Chemotherapy: 1993

1993-present: Moderator of tumor conferences at Maryview Medical Center, Portsmouth, VA

1994: Guest speaker, Oncology Nursing Society of Southeastern Virginia; subject: nutritional
      support of the cancer patient.

1996: Speaker on Chemotherapy of Neuroendocrine Tumors at NET symposium sponsored by
      EVMS Diabetes Institutes, Norfolk, VA (May 7).

       Speaker on Malignant Melanoma at symposium sponsored by Finch University of the
       Health Sciences, North Chicago, IL (June 26).

1997: Speaker at Disease Management Congress on Clinical Pathways in Oncology
      Management, Phoenix, AZ, (March 6).

       Speaker at Nursing Symposium on Cancer and the Kidney, Maryview Medical Center,
       Portsmouth, VA (May 15).

1999: Speaker at Symposium entitled HEALING: Prescriptions for Body, Mind and Spirit,
      sponsored by The Institute of Religion and Health. Talk on: Holistic Healing and
      Alternative Medicine: Fact vs. Fiction, Charleston, SC (March 6).

2000: EVMS Radio Rounds, Jan 10 and 11; topics: Cancer Detection and Cancer Prevention
                               James J. Stark, M.D., F.A.C.P. p.7




      Pros and Cons of Alternative Medicine, Presented at Lee’s Friends Biannual Retreat,
      Virginia Beach, VA (Feb. 19).

      Current Research Initiatives at Cancer Treatment Centers of America, presented to full-
      time faculty of the Department of Internal Medicine, EVMS, March 22.

      Evidence-based Alternative and Complementary Medicine, presented to Integrative
      Medicine and Internal Medicine Clubs, EVMS, April 6.

      Post-transplant Lymphoproliferative Disease, presented to tumor conference at Maryview
      Medical Center, June 23.

      Through a Glass Darkly: A Revisionist Look at Endocrine Tumors, Maryview Medical
      Center, August 18.

      New Approaches to the Treatment of Acute Myeloblastic Leukemia, Maryview Medical
      Center, September 29.

2001: Medical Grand Rounds, Department of Internal Medicine, Eastern Virginia Medical
      School, Norfolk, VA: The Role of Complementary and Alternative Medicine in the
      Prevention and Treatment of Cancer, January 31.

      Grand Rounds, Chesapeake General Hospital, Chesapeake, VA: The Role of Comple-
      mentary and Alternative Medicine in the Prevention and Treatment of Cancer, February
      9.

      Guest speaker at annual meeting of Southeastern Virginia Chapter of Oncology Nursing
      Society: Complementary Medicine in the Prevention and Treatment of Cancer, February
      21.

      Guest Speaker for continuing education forum given for the public and employees of
      Chesapeake General Hospital. Topic: Cancer and Nutrition: Holistic Healing for the
      New Millenium, February 28.

      Nelson, JK and JJ Stark, The Breasts of Night: Michelangelo as Oncologist? Presented
      at Italian Renaissance section of annual meeting of College Art Association, Chicago, IL
      March 2.

      Hodgkin’s Disease and Sarcoidosis. Presented at Maryview Medical Center, April 20.

      Chronic Myelogenous Leukemia: The impact of molecular biology on therapeutic
      options. Presented at Maryview Medical Center, August 3.

      The role of splenectomy in the management of Chronic Myelogenous Leukemia.
      Presented at Maryview Medical Center, October 5.
                               James J. Stark, M.D., F.A.C.P. p.8




2002: Small-Cell Lung Cancer: Long-term Survivors? Presented at Maryview Medical Center,
      February 1.

       Guest Speaker at “Colon Cancer Survivors Day” sponsored by Maryview Medical Center
       March 21. Topic: Colon Cancer Prevention

       The Impact of Molecular Biology on Contemporary Cancer Therapy. Medical Grand
       Rounds, EVMS, April 17.

       The Impact of Molecular Biology on Contemporary Cancer Therapy: an Update.
       Presented at Maryview Medical Center, May 31.

       Cancer of the Anus. Presented with Paul J. Kovalcik, MD, FACS at Maryview Medical
       Center, August 9.

       The Problem of the Unknown Primary Tumor. Presented at Maryview Medical Center,
       October 18.

       Neuroendocrine Large Cell Carcinoma of the lung. Presented with Joan Tryzelaar, MD,
       FACS, at Maryview Medical Center, November 8.

2003: Good Syndrome: Case report and review of the literature. Presented at Maryview
      Medical Center, January 31.

       Ocular lymphoma in a patient with Graves’ Disease: Case report and review of the
       literature. Presented at Maryview Medical Center on February 21.

       Frontiers in the Treatment of Colorectal Cancer: Role of New Ideas and New Agents.
       Presented at Colon Cancer Survivors Night, Maryview Medical Center, March 13.

       Immunosuppression (non-AIDS) and Cancer. Presented at Maryview Medical Center on
       June 6.

       Advances in the treatment of Multiple Myeloma. Presented at Maryview Medical Center
       on September 12.

       Sickle-cell Disease in the Fifth Decade. Medical Grand Rounds, EVMS, October 8.

       Recent Advances in Breast Cancer Treatment. Presented at Breast Cancer Survivors’
       Night at Harborview Medical Center, Suffolk, VA on October 23.

       Rectal lymphoma. Presented with Paul J. Kovalcik, MD, FACS, at Maryview Medical
       Center on December 12.
                                James J. Stark, M.D., F.A.C.P. p.9


2004: Hodgkin’s Disease: presented to Internal Medicine residents, Sentara Norfolk General
      Hospital, January 29.

       Sarcoma and Metabolic Bone Disease: A Failed Safari. Presented with Frank Kohler,
       D.O. at Maryview Medical Center on February 6.

       Two Unusual Intestinal Masses Presented with Paul J. Kovalcik, MD, FACS, at
       Maryview Medical Center on February 27.

       Recent advances in colon cancer. Presented at Colon Cancer Survivors Night,
       Harborview Medical Center, March 11.

       Failure to Screen for Cancer: Medical Malpractice in the New Millenium. Presented with
       A. William Charters, Esq. at Maryview Medical Center, April 2.

       Hodgkin’s Disease: Current Status. Presented at Maryview Medical Center, April 23

       Phakomatoses and Cancer. Presented at Maryview Medical Center, June 11.

       The New Malpractice Crisis: Failure to Screen for Cancer. Presented at Medical Grand
       Rounds, EVMS, August 11.

       Adjuvant chemotherapy for Stages I and II non-small-cell lung cancer. Presented at
       Maryview Medical Center, October 22.

       Evidence-based Cancer Prevention in 2004. Presented at Maryview Medical Center,
       December 10.

2005: The Variable Natural History of Renal Cell Carcinoma. Presented at Maryview Medical
      Center, February 25.

       Breast Cancer Prevention and Diagnosis. Presented at Women’s Health Symposium at
       Harborview Medical Center, Suffolk, VA, March 15.

       The New Malpractice Crisis: Failure to Screen for Cancer. Presented at monthly meeting
       of Oncology Nursing Society, Portsmouth, VA March 16.

       Sickle Cell Anemia in the Fifth Decade. Presented at Maryview Medical Center, April
       22.

       Cancer of the Renal Collecting System, Presented with Dr. William Julian at Maryview
       Medical Center on June 3.

       The Antiphospholipid Syndrome: Thrombophilia. Presented at Maryview Medical
       Center, July 8.
                               James J. Stark, M.D., F.A.C.P. p.10


       Oncologic Emergencies. Presented as part of the core curriculum to PGY-1 trainees of
       the EVMS Department of Internal Medicine, Norfolk, VA, July 20.

       Systemic Amyloidosis: New Treatment Strategies, Presented at Maryview Medical
       Center, August 12.

       Breast Cancer, 2005 Presented to First Annual Symposium on Breast Cancer Awareness
       at Maryview Medical Center, October 7 and Cancer Support Group, October 11.

       Oncologic Emergencies Presented at Maryview Medical Center, October 14

       Colon Cancer Presenting with Metastatic Disease: Management Issues, Presented at
       Maryview Medical Center on November 18.

2006: Futile Care in a Climate of Fear Presented with Madeline Stark, JD, Stephen Heretick,
      JD and Bonnie Brown, risk manager at Maryview Medical Center, January 27

       Cytogenetics for the Rest of Us: A Primer Presented with Diane Maia, MD, at
       Maryview Cancer Conference, March 3.

       Update on Colon Cancer Therapy, for Colon Cancer Awareness Month. Presented at
       Harbour View Medical Center, Suffolk, VA March 15.

       Complications of Cancer Therapy, Part I. Presented at Maryview Medical Center on
       June 9.

       Tyrosine Kinase: From Molecule to Bedside. Presented at Eastern Virginia Medical
       School Department of Internal Medicine Grand Rounds, August 9.

       Complications of Cancer Therapy Part II: Metabolic Bone Disease and Its Treatment,
       Presented at Maryview Medical Center, October 27.

2007: Breast Cancer in Young Women: Sexuality and Survival. Presented with Linda Long,
      MD, FACOG, at Maryview Medical Center, January 19.

       Adult Osteogenic Sarcoma. Presented at Maryview Medical Center, March 9.

       Thyroid Lymphoma: A modern approach to the diagnosis of an uncommon but clinically
       important lesion. Presented with Stephen I. Fisher, MD at Maryview Medical Center,
       April 20.

       Recent Advances in Cancer Diagnosis and Treatment. Presented at North Suffolk Rotary
       Club, May 18.

       Complications of Cancer Therapy Presented at Medical Grand Rounds at Eastern
       Virginia Medical School, May 23.
                              James J. Stark, M.D., F.A.C.P. p.11




      Lung Cancer in Women: A Different Disease? Presented at Maryview Medical Center,
      July 20.

      The Pre-Operative Evaluation of the Patient with Abnormal Clotting Studies,
      Presented at Maryview Medical Center, August 24.

      Invited Speaker at International Endocrine Tumor Symposium, Sponsored by EVMS,
      September 28, Sheraton Waterside Hotel, Norfolk

      Breast Cancer: Who Gets It and Who Survives? Presented at Maryview Medical Center
      on October 12.

      Stage III Lung Cancer. Presented at Lung Cancer Symposium on November 15
      sponsored by the Lung Chest Program at Maryview Medical Center at the Towne Point
      Club, Norfolk.

      Bisphosphonates in Health and Disease, Presented at Maryview Medical Center,
      November 16.

2008: Hepatocellular Carcinoma, Presented at Maryview Medical Center, January 25.

      Treatment of Locally Advanced Rectal Cancer: Current Concepts, March 27, presented
      at: “Colon Cancer: Detection, Prevention and Risk Reduction” at Hilton Garden Inn,
      Suffolk, VA

      Ductal Carcinoma-in-Situ: New Concepts and Controversies, April 18, presented at
      Maryview Medical Center.

      Osteoporosis: An Overview of the Disease and Its Consequences, April 24, presented at
      Spirit of Women presentation, Harbour View Medical Center.

      Autoimmune Hemolytic Anemia, July 18, presented at Maryview Medical Center

      New Trends in Oncology, August 1, presented at Annual Meeting of Bangladeshi
      Medical Association of North America at Norfolk Convention Center, Norfolk, VA

      Non-Seminomatous Testicular Cancer: The Poor Risk Patient, September 19, presented
      at Maryview Medical Center

      Mantle-Cell Leukemia: Lessons in Life and Death, presented at Maryview Medical
      Center, November 6.

      Melanoma Presenting as Unknown Primary with Lymph-Node Metastasis, presented
      with Dr. Jeff Riblet at Maryview Medical Center, November 21.
                               James J. Stark, M.D., F.A.C.P. p.12


       Topics in Thyroid Cancer: Insular Carcinoma and Tyrosine Kinase Inhibitors, presented
       with Dr. James LaRocque at Maryview Medical Center, December 19.

2009: Renal Cell Carcinoma: The First Sign of Von-Hippel Lindau Disease, presented with Dr.
      William Julian at Maryview Medical Center, January 9.

       Myeloproliferative Disorders: Diagnostic Enigmas, Therapeutic Dilemmas, presented at
       Maryview Medical Center, February 13.

       Bladder Cancer: Long term survivors with metastatic disease. Presented with Dr.
       William Julian, February 20.

       Osteoporosis in Youth, Aging and Illness. Presented at Riverside Regional Medical
       Center Grand Rounds, April 29.

       Gastric Lymphoma: Incidental Finding or Life Threatening Illness, presented at
       Maryview Medical Center on August 21.

       Unusual Complication of Iron Overload: Hemochromatosis? Presented at Maryview
       Medical Center on November 20.

       Palliative Care at Maryview Medical Center, Presented with Jennifer Ward, ANP- BC,
       ACHPN, AOCNP, December 18

2010   Liver Disease in Sickle Cell Anemia, presented with Dr. Elizabeth Gunderson at
       Maryview Medical Center, January 15.

       Update on the Adjuvant Therapy of Malignant Melanoma, presented at Maryview
       Medical Center, June 25.

       The Impact of Molecular Diagnostics on Contemporary Cancer Management. Presented
       at Medical Grand Rounds, Eastern Virginia Medical School, August 11.

       Ocular Melanoma Revisited Presented at Maryview Medical Center, October 11

2011   Chemotherapy for Bladder Cancer Revisited, presented at Maryview, January 26

       Hormone-resistant Prostate Cancer, presented at Maryview Medical Center, March 11.

       Meetastatic Melanoma from Unknown Primary, presented at Maryview March 25

       Unusual Complication of Melanoma therapy, presented at Maryview May 22


2012   Medical Errors: How and Why Good Doctors Make Bad Mistakes. Presented at Medical
       Grand Rounds, Eastern Virginia Medical School, April 12.
                                James J. Stark, M.D., F.A.C.P. p.13




       Internal Medicine Board Review Course given to PG III Internal Medicine Residents to
       prepare them for the Oncology Section of the Internal Medicine Board Examination,
       March and April, 2012.

FUNDED RESEARCH

Foundation Funding:

Micronutrient Intervention Trial: A Pilot Study, funded by Cancer Treatment Research
Foundation at $155,000 (principal investigator and author of grant proposal) (1999-2001).

Pharmaceutical Company Research (selected trials, acting as site principal investigator):

Pfizer: A Phase III trial of liposome encapsulated Doxorubicin versus Doxorubicin in the
treatment of metastatic breast cancer (1996-1997).

Alfacell, Inc.: Onconase® versus Doxorubicin: A Phase III trial in the treatment of mesothelioma
(1995-1997).

Eli Lilly: LY231514 (MTA): A Phase III trial for the treatment of mesothelioma (2000-2001).

Vical, Inc.: VCL-1005-301: A Phase III trial for the treatment of metastatic melanoma (2000-
2002).

Ligand Pharmaceuticals: A Phase III trial of best available chemotherapy with or without
Targretin® in patients with Stage IIIB and IV lung cancer (2002-2003).

Amgen: Quality of Life Study for patients receiving growth-factor support (2003-2004).

Amgen: Quality of Life Study in patients receiving Pegylated Filgrastim (2004-ff).

Syntapharma: Combination therapy for the treatment of advanced melanoma with Paclitaxel plus
or minus STA-4783: a Phase III trial (2004-2006).

Numerous funded trials through ACORN (Accelerated Community Oncology Research
Network) 2008-2011.


PUBLICATIONS -- ORIGINAL CONTRIBUTIONS

Stark, JJ, CA Sanders and WJ Powell, Jr. Neurally Mediated and Direct Effects of
Acetylstrophanthidin on Canine Skeletal Muscle Vascular Resistance, Circulation Research 30:
274-282, 1972.
                                James J. Stark, M.D., F.A.C.P. p.14


Willerson, JT, WJ Powell, Jr., TE Guiney, JJ Stark, CA Sanders and A Leaf Improvement in
Myocardial Function and Coronary Blood Flow in Ischemic Myocardium After Mannitol,
Journal of Clinical Investigation 51: 2989-2998, 1972.

Stark, JJ and SB Howell Clinical Investigations of the Nephrotoxicity of Cis-platinum (II)
Dichlorodiammine, Clinical Pharmacology and Therapeutics 23: 461-466, 1978.

Garnick, MB, GP Canellos, JP Richie and JJ Stark Sequential Combination Chemotherapy and
Surgery for Disseminated Testicular Cancer, Cancer Treatment Reports 63:1681-1686, 1979.

Stark, JJ, JW Lloyd and PF Schellhammer Estrogen Receptor Activity and Hormonal
Responsiveness in a Patient with Hodgkin's Disease, Ann Int Med 95: 186-187, 1981.

Pesando, JM, SE Come, JJ Stark, LM Parker, CT Griffiths, and GP Canellos Cis
Diamminodichloro Platinum (II) Therapy for Advanced Ovarian Cancer. Cancer Treatment
Reports 64: 1147-1148, 1981.

Oldham, RK, J Stark, NM Barth, B Hoogstraten, CH Brown, T O'Connor, S Dupere and R. Birch
Continuous Infusion of Interleukin-2 and Cyclophosphamide as Treatment of Advanced
Cancers: A National Biotherapy Study Group Trial, Molecular Biotherapy 3: 74-78, 1991.

Stark, JJ Epilogue to Eastern Virginia Cancer Statistics Review: 1985-1989. Edited by AJ
Rosenthal. 1992, published by Tidewater Regional Cancer Network.

Stark JJ Sequencing of Chemotherapy and Radiotherapy in Breast Cancer. Letter to the Editor
(ré: Recht A et al N Engl J Med 334:1356-61, 1996). New England Journal of Medicine
335:1240, 1996.

Stark JJ, R Dillman, R Schulof, M Wiemann, N Barth, P Honeycutt and G Soori Interferon-
and Chemohormonal Therapy for Patients with Advanced Melanoma: Final Results of a Phase
I-II Study of the Cancer Biotherapy Research Group and the Mid-Atlantic Oncology Program
CANCER 82 (9): 1677-81, 1998.

Miller, DR, GT Anderson, JJ Stark, JL Granick and D Richardson Phase I/II Trial of the Safety
and Efficacy of Shark Cartilage in the Treatment of Advanced Cancer. Journal of Clinical
Oncology 16 (11): 3649-55, 1998.

Soori, GS, RS Schulof, JJ Stark, MC Wiemann, PJ Honeycutt, CK Church and CB DePriest
Continuous Infusion Floxuridine and Alpha Interferon in Metastatic Renal Cancer: A National
Biotherapy Study Group Phase II Study. Cancer Investigation, 17 (6): 379-384, 1999.

Stark, JJ and JK Nelson The Breasts of “Night”: Michelangelo as Oncologist. New England
Journal of Medicine, 343 (21): 1577-8, 2000.

Soori G, RO Dillman, MC Wiemann, JJ Stark, DF Tai, CB DePriest, CK Church and R Schulof
Phase II Trial of Subcutanious Interleukin-2, Subcutaneous Interferon-, 5-Fluourouracil and
                                James J. Stark, M.D., F.A.C.P. p.15


Cis-retinoic Acid in the Treatment of Metastatic Renal Cell Carcinoma: Final Results of Cancer
Biotherapy Research Group 94-10. Cancer Biotherapy and Radiopharmaceuticals 17 (2):165-
173, 2002.

Stark JJ. Prevention of Hepatocellular Carcinoma. Annals of Internal Medicine 141 (1): 77,
2004.

Stark, JJ, J Roman, RM Newsom, D Richardson and JC LaRocque Orbital MALT Lymphoma in
a Patient with Graves’ Ophthalmopathy: a Unique Observation, Cancer Investigation 23:593-5,
2005.

Dillman RO, MC Wiemann, F Tai, CB DePriest, G Soori, JJ Stark, K Mahdavi, C Church Phase
II Trial of Subcutaneous Interferon Followed by Intravenous Hybrid Bolus/Continuous Infusion
Interleukin-2 in the Treatment of Renal Cell Carcinoma: Final Results of Cancer Biotherapy
Research Group 95-09. Cancer Biotherapy & Radiopharmaceuticals. 21(2):130-7, 2006.

Stark, JJ Electronic Health Records: Who Pays? Annals of Internal Medicine 145 (11):864,
2006.

Watring, NJ, Wagner TW and Stark JJ Spontaneous splenic rupture secondary to pegfilgrastim to
prevent neutropenia in a patient with non-small-cell lung carcinoma. Am J Emerg Med 25
(2):247-8, 2007

Stark, JJ Alcaligenes xylosoxidans osteomyelitis without trauma in a patient with Good
syndrome, European Journal of Internal Medicine, 18 (5):447, 2007.

Stark, JJ Frontispiece text for Bland and Copeland, eds. The Breast: Comprehensive
Management of Benign and Malignant Disorders 4th edition Elsevier Publishers, Philadelphia,
PA, 2009, p. ii.

PUBLICATIONS – REVIEWS

Stark, JJ An Approach to the Patient with Testicular Cancer, in The Cure of Cancer, a syllabus
prepared for a course sponsored by Harvard Medical School, 1977.

Canellos, GP and JJ Stark Medical Emergencies in Oncology, in Cancer: A Manual for
Practitioners Massachusetts Division of American Cancer Society, 300-306, 1979.

Stark, JJ Cancer of the Pancreas -- Diagnosis and Treatment, Virginia Medical Monthly 108:
541-543, 1981.


PUBLICATIONS – INVITED EDITORIALS
                               James J. Stark, M.D., F.A.C.P. p.16


Stark, JJ, T Birdsall, G Anderson, D Nixon E Zang and G Haase Micronutrient
Supplementation for Patients with Metastatic Cancer. Nutrition and Cancer 38 (2): 296-298,
2000.


ABSTRACTS

Stark, JJ SB Howell and J Carmody Prevention of Cis-platinum Nephrotoxicity. Clinical
Research.25: 412A, 1977.

Stark JJ, MB Garnick and GP Canellos The Value of Surgical Restaging in Advanced Testicular
Cancer, Virginia Medical Monthly January, 1978, p. 61.

Oldham, RK, J Stark, N Barth, B Hoogstraten, CH Brown, S Dupere, R. Birch Treatment of
advanced cancers with cytoxan (CTX) and interleukin-2 (rIL-2): a phase II study. Proc Am
Assoc Cancer Research 31:268, 1990.

Stark, JJ RS Schulof and M Wiemann Alpha Interferon and Chemo-Hormonal Therapy in
Advanced Melanoma: A Phase I-II National Biotherapy Study Group/Mid-Atlantic Oncology
Program Study. Presented at sixth annual meeting of Society for Biological Therapy, November
16-19, 1991, p. 20 of abstract booklet.

Stark, JJ, R Schulof, M Wiemann, N Barth and P Honeycutt Alpha Interferon and Chemo-
Hormonal Therapy in Advanced Melanoma: Update of A Phase I-II NBSG/MAOP Study
Journal of Immunotherapy 13 (1): 72-73, 1993.
Stark JJ, R Schulof, M Wiemann, N Barth, P Honeycutt and G Soori Alpha Interferon and
Chemo-Hormonal Therapy in Advanced Melanoma: A Phase I-II NBSG/MAOP Study Proc Am
Soc Clin Onc 12 (3):392, 1993.

Soori G, R Schulof, J. Stark, M. Wiemann, P. Honeycutt, J. Arnold and C. Church Phase II Trial
of Continuous Infusion (CI) Floxuridine (FUDR) and interferon-Alpha-2b (a-IFN-2b) in
Advanced Renal Cancer -- An NBSG Study Proc Am Soc Clin Onc 12 (3):236, 1993.

Hankenson R, H Nevinny, A Hankenson, F Brunk, J Stark, D Miller, and RM Williams
Malignant Epidural Spinal Cord Compression in Breast Cancer Proc Am Soc Clin Onc 12
(3):86, 1993.

Soori G, R Schulof, J Stark, M Wiemann, R Langdon and M Block Continuous Infusion
Floxuridine and Interferon-Alpha 2b in Advanced Renal Cancer -- An NBSG Phase II Study.
Presented at eighth annual meeting of the Society for Biological Therapy, November 10-14,
1993 in Nashville, TN p. 56 abstract book.

Stark J, J Frank, J Granick, D Miller, R Levin, P Sirijintakarn, D Wong, R Sanchez, A Mellijor
and RM Williams Combined Intra-arterial and Intravenous Chemotherapy for Locally Advanced
Carcinoma of the Pancreas. Proc Am Soc Clin Onc 13 (3):226, 1994.
                                James J. Stark, M.D., F.A.C.P. p.17


Stark JJ, R Schulof, M Wiemann, N Barth, P Honeycutt and G Soori Alpha Interferon and
Chemo-Hormonal Therapy in Advanced Melanoma: Final Results of a Phase I-II Study.
Presented at the Sixteenth Annual Seminar of Cancer Researchers in Virginia, March 30, 1996,
in Norfolk, VA Abstract #50 in program book.

Miller DR, JL Granick, JJ Stark, GT Anderson Phase I/II Trial of the Safety and Efficacy of
Shark Cartilage (Cartilade) in the Treatment of Advanced Cancers. Proc Am Soc Clin Onc
16:49a, 1997.

Soori G, JJ Stark, MC Wiemann, PJ Honeycutt, BE Cogburn, DF Tai, C DePriest, LA Potts, C
Church, R Schulof, and RO Dillman Outpatient Phase II Trial of Alpha Interferon,
Subcutaneous Interleukin-2, 5-Fluorouracil, and Cis-Retinoic Acid in Patients with Metastatic
Renal Cell Cancer. Proc Am Soc Clin Onc 16:344a, 1997.

Soori G, JJ Stark, M Wiemann, P Honeycutt, D Tai, T Dobbs, R. Langdon, B Cogburn, M Block,
P Townley, R Dillman, C Church, and C DePriest Outpatient Phase II Trial of Alpha Interferon,
Subcutaneous Interleukin-2, 5-Fluorouracil and Cis-Retinoic Acid in Patients with Metastatic
Renal Cell Cancer. Proc Am Soc Clin Onc 18: 352a, 1999.

Dillman RO, MC Wiemann, F Tai, CB DePriest, G Soori, JJ Stark, K Mahdavi, and CK Church
Phase II trial of subcutaneous interferon followed by hybrid bolus/continuous infusion
Interleukin-2 in the treatment of renal cell carcinoma: final results of Cancer Biotherapy
Research Group (CBRG) 95-09. Submitted to the 2005 meeting of the Society for Biological
Therapy.

Watring, NJ, JJ Stark, and TW Wagner Spontaneous splenic rupture after pegfilgrastim
administration. Presented at Eastern Virginia Medical School 18th Annual Research Day.

								
To top